Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Receivables: 2009-2025

Historic Change in Receivables for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $244,000.

  • Rockwell Medical's Change in Receivables rose 112.43% to $244,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$549,000, marking a year-over-year decrease of 13.43%. This contributed to the annual value of -$2.6 million for FY2024, which is 156.23% down from last year.
  • As of Q3 2025, Rockwell Medical's Change in Receivables stood at $244,000, which was up 115.38% from -$1.6 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Change in Receivables peaked at $4.0 million during Q3 2023, and registered a low of -$2.0 million during Q3 2024.
  • For the 3-year period, Rockwell Medical's Change in Receivables averaged around $188,091, with its median value being -$238,000 (2023).
  • Per our database at Business Quant, Rockwell Medical's Change in Receivables tumbled by 800.81% in 2022 and then surged by 646.33% in 2023.
  • Over the past 5 years, Rockwell Medical's Change in Receivables (Quarterly) stood at -$123,000 in 2021, then crashed by 800.81% to -$1.1 million in 2022, then surged by 238.99% to $1.5 million in 2023, then tumbled by 138.05% to -$586,000 in 2024, then surged by 112.43% to $244,000 in 2025.
  • Its Change in Receivables was $244,000 in Q3 2025, compared to -$1.6 million in Q2 2025 and $1.4 million in Q1 2025.